Legato Capital Management LLC Insulet Corp Transaction History

Legato Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$154.67 - $290.89 $587,746 - $1.11 Million	3,800 New	3,800 $606,000
Q2 2023 Aug 17, 2023	SELL	$272.48 - $330.23 $609,537 - $738,724	-2,237 Reduced 33.36%	4,468 $1.29 Million
Q4 2022 Feb 01, 2023	BUY	$212.22 - $313.46 $1.42 Million - $2.1 Million	6,705 New	6,705 $1.97 Million
Q3 2021 Nov 09, 2021	SELL	$260.36 - $307.27 $246,560 - $290,984	-947 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$225.52 - $304.06 $213,567 - $287,944	947 New	947 $260,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Legato Capital Management LLC with notifications on news.